Do you want to read an article? Please log in or register.
Genetic effects on efficacy to fluticasone propionate/salmeterol treatment in COPD
COPD
Related content
COMMENTED
Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non-frequently exacerbating COPD patients: The FLASH randomized controlled trial
Respirology.
Frith PA, Ashmawi S, Krishnamurthy S, Gurgun A, Hristoskova S, Pilipovic V, Hamann AM, Backer A, Olsson P, Kostikas K, Diaz DV, FLASH Investigators
doi: 10.1111/resp.13374.
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD (FLAME study)
N Engl J Med.
Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators
doi: 10.1056/NEJMoa1516385.
RECOMMENDED
COPD
Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study
Respir Res.
Wedzicha JA, Singh D, Tsiligianni I, Jenkins C, Fucile S, Fogel R, Shen S, Goyal P, Mezzi K, Kostikas K
doi: 10.1186/s12931-019-0972-7.
COPD
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
Int J Chron Obstruct Pulmon Dis.
Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R
doi: 10.2147/COPD.S133307.
RECOMMENDED
COPD
No genetic associations with mepolizumab efficacy in COPD with peripheral blood eosinophilia
Respir Med.
Condreay LD, Gao C, Bradford E, Yancey SW, Ghosh S
doi: 10.1016/j.rmed.
RECOMMENDED
COPD
Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups
Respir Med.
Bakerly ND, Woodcock A,
Collier S, Leather DA, New JP,
Crawford J, Harvey C, Vestbo J,
Boucot I
doi: 10.1016/j.rmed.2018.12.016.
Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice
N Engl J Med.
Vestbo J, Leather D, Diar Bakerly N, New J, Gibson JM, McCorkindale S, Collier S, Crawford J, Frith L, Harvey C, Svedsater H, Woodcock A; Salford
doi: 10.1056/NEJMoa1608033
RECOMMENDED
COPD
Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Król A, Palmér R, Rondeau V, Rennard S, Eriksson UG, Jauhiainen A
doi: 10.1186/s12931-020-01419-8.
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysis.
Respir Med.
Papi A, Price D, Sastre J, Kaiser K, Lomax M, McIver T, Dissanayake S
doi: 10.1016/j.rmed.2014.10.019.